HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K Yoshimura Selected Research

Calcium Oxalate

9/2001Strong inhibition of crystal-cell attachment by pediatric urinary macromolecules: a close relationship with high urinary citrate secretion.
11/2000Fibronectin as a potent inhibitor of calcium oxalate urolithiasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


K Yoshimura Research Topics

Disease

10Neoplasms (Cancer)
01/2022 - 09/2000
4Breast Neoplasms (Breast Cancer)
01/2020 - 01/2001
3Pain (Aches)
02/2016 - 08/2004
3Infections
09/2001 - 03/2000
2Esophageal Squamous Cell Carcinoma
02/2016 - 11/2000
2Renal Cell Carcinoma (Grawitz Tumor)
04/2013 - 09/2001
2Uveitis
01/2008 - 11/2007
2Prostatic Neoplasms (Prostate Cancer)
01/2007 - 01/2004
2Granuloma
01/2005 - 05/2001
2Hyperthermia
12/2004 - 08/2004
2Fever (Fevers)
08/2004 - 01/2000
2Lung Neoplasms (Lung Cancer)
08/2004 - 03/2003
2Hyperpigmentation
04/2003 - 03/2000
2Urolithiasis
09/2001 - 11/2000
2Hemorrhage
06/2001 - 01/2000
1Muscular Dystrophies (Muscular Dystrophy)
10/2017
1Ulcer
02/2016
1Heartburn (Pyrosis)
02/2016
1Squamous Cell Neoplasms (Squamous Cell Cancer)
02/2016
1Gastroesophageal Reflux (GERD)
02/2016
1Pulmonary Tuberculosis
01/2015
1Pemphigus (Pemphigus Vulgaris)
09/2014
1Wound Infection (Wound Infections)
01/2012
1Pneumonia (Pneumonitis)
09/2011
1Stomach Neoplasms (Stomach Cancer)
06/2011
1Pathologic Complete Response
07/2010
1Carcinoma (Carcinomatosis)
07/2010
1Convulsions benign familial neonatal dominant form
10/2009
1Hypoxia (Hypoxemia)
10/2009
1Necrosis
10/2009
1Lipoma (Lipomata)
10/2009
1Asthma (Bronchial Asthma)
01/2009
1Inflammation (Inflammations)
01/2008
1Cystitis
01/2008
1Cataract (Cataracts)
11/2007
1Infarction (Infarctions)
10/2007
1Hydrocephalus (Hydrocephaly)
10/2007
1Lung Diseases (Lung Disease)
06/2007
1Varicose Veins (Varicose Vein)
11/2005

Drug/Important Bio-Agent (IBA)

3Immunoglobulin A (IgA)IBA
01/2015 - 07/2000
3AntigensIBA
07/2001 - 03/2000
2AutoantibodiesIBA
09/2014 - 07/2001
2Messenger RNA (mRNA)IBA
10/2009 - 11/2001
2N,N-dimethylarginine (asymmetric dimethylarginine)IBA
01/2008 - 11/2007
2Matrix Metalloproteinases (MMPs)IBA
11/2005 - 03/2001
2CarrageenanIBA
12/2004 - 08/2004
2Cisplatin (Platino)FDA LinkGeneric
03/2003 - 11/2000
2Interleukin-5 (Interleukin 5)IBA
04/2002 - 05/2001
2Tretinoin (Retinoic Acid)FDA LinkGeneric
11/2001 - 03/2001
2Calcium OxalateIBA
09/2001 - 11/2000
2Interleukin-6 (Interleukin 6)IBA
05/2001 - 09/2000
2CytokinesIBA
05/2001 - 01/2000
2hydroquinone (Esoterica)FDA Link
03/2001 - 03/2000
1LipidsIBA
01/2020
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
10/2017
1Proton Pump InhibitorsIBA
02/2016
1human ERBB2 proteinIBA
12/2014
1Sulfhydryl Compounds (Thiols)IBA
09/2014
1envoplakinIBA
09/2014
1Pharmaceutical PreparationsIBA
09/2014
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
04/2013
1Protein Subunit VaccinesIBA
04/2013
1Docetaxel (Taxotere)FDA Link
09/2012
1Dihydrotachysterol (AT 10)IBA
09/2012
1Virulence Factors (Pathogenicity Factors)IBA
09/2011
1Membrane Proteins (Integral Membrane Proteins)IBA
09/2011
1S-1 plus cisplatinIBA
06/2011
1Trastuzumab (Herceptin)FDA Link
07/2010
1PotassiumIBA
10/2009
1Plasminogen Activators (Plasminogen Activator)IBA
10/2009
1AdiponectinIBA
10/2009
1LeptinIBA
10/2009
1Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
10/2009
1PPAR gammaIBA
10/2009
1LectinsIBA
10/2009
1SolutionsIBA
01/2009
1Detergents (Detergent)IBA
01/2009
1Ethanolamine (Colamine)IBA
01/2009
1Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
01/2009
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2008
1Biomarkers (Surrogate Marker)IBA
01/2008
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2008
1pigment epithelium-derived factorIBA
11/2007
1EnzymesIBA
11/2007
1ImmunosorbentsIBA
11/2007
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
11/2005
1Oxidoreductases (Dehydrogenase)IBA
11/2005
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
11/2005
1Simvastatin (Zocor)FDA LinkGeneric
11/2005
1Pravastatin (Pravachol)FDA LinkGeneric
11/2005

Therapy/Procedure

5Therapeutics
02/2016 - 09/2000
3Drug Therapy (Chemotherapy)
01/2022 - 01/2000
3Radiotherapy
01/2007 - 12/2000
2Nephrectomy
06/2001 - 02/2001
1Conservative Treatment
01/2012
1Adjuvant Chemotherapy
06/2011
1Gastrectomy
06/2011
1Neoadjuvant Therapy
07/2010
1Ventriculostomy
10/2007
1Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
01/2007